Bristol Myers Squibb
Bristol Myers Squibb (BMS) is a global Fortune 500 biopharmaceutical company committed to discovering, developing, and delivering innovative medicines for patients with serious diseases. BMS focuses on oncology, immunology, cardiovascular, fibrosis, and cell therapy (CAR T). The company operates BMS Study Connect for clinical trial recruitment, a Medical Information portal for healthcare providers, and the BMS Business Development platform for research partnerships and data sharing. BMS actively pursues technology partnerships in protein degradation, advanced treatment modalities, and digital health.
APIs
BMS Medical Information Portal
The BMS Medical Information portal provides US healthcare providers with access to product medical information, clinical data, and scientific resources for BMS medicines across ...
BMS Study Connect
BMS Study Connect is a clinical trial recruitment and information platform enabling patients and caregivers to find and enroll in Bristol Myers Squibb sponsored clinical researc...
Pricing Plans
Rate Limits
FinOps
Bristol Myers Squibb Finops
FINOPSPress
Science Firsthand: Predicting new possibilities in drug ...
2026-05-25
Corporate news details
2026-05-25
Tempus Expands Strategic Collaboration with Bristol Myers ...
2026-05-25
Evinova, Bristol Myers Squibb Partner to Apply AI to Global ...
2026-05-25
Our technologies
2026-05-25